WENDY L DIXON Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WENDY L DIXON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WENDY L DIXON. WENDY L DIXON is a CMO & Pres, Global Marketing in BRISTOL MYERS SQUIBB CO ($BMY) and a Director in INCYTE CORP ($INCY) and a in bluebird bio, Inc. ($BLUE) and a Director in bluebird bio, Inc. ($BLUE) and a Director in Orexigen Therapeutics, Inc. ($OREX) and a Director in Eleven Biotherapeutics, Inc. ($EBIO) and a Director in Alkermes plc. ($ALKS) and a Director in Voyager Therapeutics, Inc. ($VYGR) and a Director in ARVINAS, INC. ($ARVN).
Address: BRISTOL-MYERS SQUIBB COMPANY RT. 206 & PROVINCELINE ROAD PRINCETON 08540 NJ
Companies in which WENDY L DIXON is an Insider
Alkermes plc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WENDY L DIXON: Director
Holdings: 61,600 shares
Current Value: $3,373,832
Latest Transaction: Apr 20 2021
$ALKS Market Capitalization: $8.28B
$ALKS Previous Close: $54.77
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARVINAS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WENDY L DIXON: Director
Holdings: 0 shares
Latest Transaction: Jul 01 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
bluebird bio, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of WENDY L DIXON:
Holdings: 4,153 shares
Current Value: $306,076
Latest Transaction: Jun 22 2020
$BLUE Market Capitalization: $2.75B
$BLUE Previous Close: $73.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BRISTOL MYERS SQUIBB CO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WENDY L DIXON: CMO & Pres, Global Marketing
Holdings: 87,003 shares
Current Value: $4,494,575
Latest Transaction: May 24 2006
$BMY Market Capitalization: $87.00B
$BMY Previous Close: $51.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INCYTE CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of WENDY L DIXON: Director
Holdings: 14,878 shares
Current Value: $1,758,282
Latest Transaction: Apr 01 2021
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Orexigen Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WENDY L DIXON: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 10 2015
$OREX Market Capitalization: $70.30M
$OREX Previous Close: $4.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sesen Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WENDY L DIXON: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 21 2019
$SESN Market Capitalization: $34.48M
$SESN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Voyager Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of WENDY L DIXON: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 05 2020
$VYGR Market Capitalization: $316.10M
$VYGR Previous Close: $11.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of WENDY L DIXON
Sentiment: All, ALKS, ARVN, BLUE, BMY, INCY, OREX, SESN, VYGR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20 2021 | ALKS | Alkermes plc. | DIXON WENDY L | Director | Option Exercise | M | 14.60 | 25,000 | 365,000 | 0 | |
| Apr 20 2021 | ALKS | Alkermes plc. | DIXON WENDY L | Director | Sell | S | 20.00 | 25,000 | 500,120 | 36,600 | 61.6 K to 36.6 K (-40.58 %) |
| Apr 20 2021 | ALKS | Alkermes plc. | DIXON WENDY L | Director | Buy | M | 14.60 | 25,000 | 365,000 | 61,600 | 36.6 K to 61.6 K (+68.31 %) |
| Apr 01 2021 | INCY | INCYTE CORP | DIXON WENDY L | Director | Grant | A | 81.27 | 225 | 18,286 | 14,878 | 14.7 K to 14.9 K (+1.54 %) |
| Jan 15 2021 | ALKS | Alkermes plc. | DIXON WENDY L | Director | Option Exercise | M | 12.62 | 20,000 | 252,400 | 0 | |
| Jan 15 2021 | ALKS | Alkermes plc. | DIXON WENDY L | Director | Option Exercise | M | 12.62 | 15,000 | 189,300 | 0 | |
| Jan 15 2021 | ALKS | Alkermes plc. | DIXON WENDY L | Director | Option Exercise | M | 12.62 | 20,000 | 252,400 | 0 |